SCOPUS 정보 검색 플랫폼

Cardiology in Review

Volumn 20, Issue 1, 2012, Pages 4-7

Vascular ehlers-Danlos syndrome: Pathophysiology, diagnosis, and prevention and treatment of its complications

(2) Beridze, Natalia a Frishman, William H b

a Mount Vernon Hospital USA (United States)

b WESTCHESTER MEDICAL CENTER (United States)

Author keywords

adrenergic blockade; celiprolol; ehlers Danlos syndrome type 4; vascular ehlers Danlos syndrome; vascular rupture

Indexed keywords

CELIPROLOL; COLLAGEN TYPE 3; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA;

BETA ADRENERGIC RECEPTOR BLOCKING; COL3A1 GENE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SURVEILLANCE; DRUG ACTIVITY; EHLERS DANLOS SYNDROME; GENE; GENE MUTATION; GENETIC COUNSELING; HEMODYNAMICS; HUMAN; INCIDENCE; PATHOGENESIS; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SURVIVAL RATE; VASCULAR EHLERS DANLOS SYNDROME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; COLLAGEN TYPE III; EHLERS-DANLOS SYNDROME; GENETIC COUNSELING; HUMANS; INTRAOPERATIVE COMPLICATIONS; MORTALITY, PREMATURE; MUTATION; RUPTURE, SPONTANEOUS; VASCULAR DISEASES;

EID: 83155190236 PISSN: 10615377 EISSN: 15384683 Source Type: Journal
DOI: 10.1097/CRD.0b013e3182342316 Document Type: Review

Times cited : (43)

References (27)

1
- 34548760860
- Ehlers-Danlos syndrome type IV
- Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis. 2007;2:32.
- (2007) Orphanet J Rare Dis , vol.2 , pp. 32
- Germain, D.P.¹

2
- 0034054910
- Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type
- DOI 10.1056/NEJM200003093421001
- Pepin M, Schwarze U, Superti-Furga A, et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342:673-680. (Pubitemid 30131419)
- (2000) New England Journal of Medicine , vol.342 , Issue.10 , pp. 673-680
- Pepin, M.¹ Schwarze, U.² Superti-Furga, A.³ Byers, P.H.⁴

3
- 78049527006
- Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: A prospective randomised, open, blinded-endpoints trial
- Ong KT, Perdu J, De Backer J, et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet. 2010;376:1476-1484.
- (2010) Lancet , Issue.376 , pp. 1476-1484
- Ong, K.T.¹ Perdu, J.² De Backer, J.³

4
- 0023944379
- Ehlers-Danlos syndrome type IV: A multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen
- Superti-Furga A, Gugler E, Gitzelmann R, et al. Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen. J Biol Chem. 1988;263:6226-6232.
- (1988) J Biol Chem , vol.263 , pp. 6226-6232
- Superti-Furga, A.¹ Gugler, E.² Gitzelmann, R.³

5
- 55049111910
- Vascular type of Ehlers-Danlos syndrome
- Watanabe A, Shimada T. Vascular type of Ehlers-Danlos syndrome. J Nihon Med Sch. 2008;75:254-261.
- (2008) J Nihon Med Sch , vol.75 , pp. 254-261
- Watanabe, A.¹ Shimada, T.²

6
- 0032574641
- Ehlers-danlos syndromes: Revised nosology, Villefranche, 1997
- DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O
- Beighton P, De Paepe A, Steinmann B, et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998;77:31-37. (Pubitemid 28176360)
- (1998) American Journal of Medical Genetics , vol.77 , Issue.1 , pp. 31-37
- Beighton, P.¹ De Paepe, A.² Steinmann, B.³ Tsipouras, P.⁴ Wenstrup, R.J.⁵

7
- 77956212682
- In: Pagon RA, Bird TD, Dolan CR, et al, eds: GeneReviews (Internet). September 2, 1999: Seattle, WA: University of Washington. Updated June 7
- Pepin MG, Byers PH. Ehlers-Danlos syndrome, vascular type. In: Pagon RA, Bird TD, Dolan CR, et al, eds: GeneReviews (Internet). September 2, 1999: Seattle, WA: University of Washington. Updated June 7, 2006.
- (2006) Ehlers-Danlos Syndrome, Vascular Type
- Pepin, M.G.¹ Byers, P.H.²

8
- 10344257996
- Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders
- DOI 10.1111/j.1365-2141.2004.05220.x
- De Paepe A, Malfait F. Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol. 2004;127:491-500. (Pubitemid 39627173)
- (2004) British Journal of Haematology , vol.127 , Issue.5 , pp. 491-500
- De Paepe, A.¹ Malfait, F.²

9
- 50349096254
- Report of the national heart, lung, and blood institute and national marfan foundation working Group on research in Marfan syndrome and related disorders
- Pearson GD, Devereux R, Loeys B, et al. Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. Circulation. 2008;118:785-791.
- (2008) Circulation , vol.118 , pp. 785-791
- Pearson, G.D.¹ Devereux, R.² Loeys, B.³

10
- 33747812887
- Aneurysm syndromes caused by mutations in the TGF-β receptor
- DOI 10.1056/NEJMoa055695
- Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355:788-798. (Pubitemid 44285584)
- (2006) New England Journal of Medicine , vol.355 , Issue.8 , pp. 788-798
- Loeys, B.L.¹ Schwarze, U.² Holm, T.³ Callewaert, B.L.⁴ Thomas, G.H.⁵ Pannu, H.⁶ De Backer, J.F.⁷ Oswald, G.L.⁸ Symoens, S.⁹ Manouvrier, S.¹⁰ Roberts, A.E.¹¹ Faravelli, F.¹² Alba Greco, M.¹³ Pyeritz, R.E.¹⁴ Milewicz, D.M.¹⁵ Coucke, P.J.¹⁶ Cameron, D.E.¹⁷ Braverman, A.C.¹⁸ Byers, P.H.¹⁹ De Paepe, A.M.²⁰ Dietz, H.C.²¹ more..

11
- 78049528435
- Celiprolol therapy for vascular Ehlers-Danlos syndrome
- Brooke BS. Celiprolol therapy for vascular Ehlers-Danlos syndrome. Lancet. 2010;376:1443-1444.
- (2010) Lancet , vol.376 , pp. 1443-1444
- Brooke, B.S.¹

12
- 79954416361
- Cross-sectional and longitudinal assessment of aortic root dilation and valvular anomalies in hypermobile and classic Ehlers-Danlos syndrome
- e1
- Atzinger CL, Meyer RA, Khoury PR, et al. Cross-sectional and longitudinal assessment of aortic root dilation and valvular anomalies in hypermobile and classic Ehlers-Danlos syndrome. J Pediatr. 2011;158:826-830.e1.
- (2011) J Pediatr , vol.158 , pp. 826-830
- Atzinger, C.L.¹ Meyer, R.A.² Khoury, P.R.³

13
- 0030740026
- Clinical and echocardiographic survey of the Ehlers-Danlos syndrome
- Dolan AL, Mishra MB, Chambers JB, et al. Clinical and echocardiographic survey of the Ehlers-Danlos syndrome. Br J Rheumatol. 1997;36:459-462.
- (1997) Br J Rheumatol , vol.36 , pp. 459-462
- Dolan, A.L.¹ Mishra, M.B.² Chambers, J.B.³

14
- 22044433881
- The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience
- DOI 10.1016/j.jvs.2005.03.053, PII S0741521405005409
- Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg. 2005;42:98-106. (Pubitemid 40966082)
- (2005) Journal of Vascular Surgery , vol.42 , Issue.1 , pp. 98-106
- Oderich, G.S.¹ Panneton, J.M.² Bower, T.C.³ Lindor, N.M.⁴ Cherry Jr., K.J.⁵ Noel, A.A.⁶ Kalra, M.⁷ Sullivan, T.⁸ Gloviczki, P.⁹

15
- 72549087520
- Contemporary management of vascular complications associated with Ehlers-Danlos syndrome
- Brooke BS, Arnaoutakis G, McDonnell NB, et al. Contemporary management of vascular complications associated with Ehlers-Danlos syndrome. J Vasc Surg. 2010;51:131-139.
- (2010) J Vasc Surg , vol.51 , pp. 131-139
- Brooke, B.S.¹ Arnaoutakis, G.² McDonnell, N.B.³

16
- 1842591052
- Increased carotid wall stress in vascular ehlers-danlos syndrome
- DOI 10.1161/01.CIR.0000121741.50315.C2
- Boutouyrie P, Germain DP, Fiessinger JN, et al. Increased carotid wall stress in vascular Ehlers-Danlos syndrome. Circulation. 2004;109:1530-1535. (Pubitemid 38420182)
- (2004) Circulation , vol.109 , Issue.12 , pp. 1530-1535
- Boutouyrie, P.¹ Germain, D.P.² Fiessinger, J.-N.³ Laloux, B.⁴ Perdu, J.⁵ Laurent, S.⁶

17
- 76649100088
- TGF-beta in the pathogenesis and prevention of disease: A matter of aneurysmic proportions
- Dietz HC. TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. J Clin Invest. 2010;120:403-407.
- (2010) J Clin Invest , Issue.120 , pp. 403-407
- Dietz, H.C.¹

18
- 50549084575
- Transforming growth factor-beta signaling in thoracic aortic aneurysm development: A paradox in pathogenesis
- Jones JA, Spinale FG, Ikonomidis JS. Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res. 2009;46:119-137.
- (2009) J Vasc Res , vol.46 , pp. 119-137
- Jones, J.A.¹ Spinale, F.G.² Ikonomidis, J.S.³

19
- 78049530983
- The role of circulating transforming growth factor-in vascular Ehlers-Danlos syndrome: Implications for drug therapy
- Schoenhoff FS, Griswold BF, Matt P, et al. The role of circulating transforming growth factor-in vascular Ehlers-Danlos syndrome: implications for drug therapy. Circulation. 2009;120:S1048.
- (2009) Circulation , vol.120
- Schoenhoff, F.S.¹ Griswold, B.F.² Matt, P.³

20
- 0026025846
- Clinical perspective on celiprolol: Cardioprotective potential
- Frishman WH. Clinical perspective on celiprolol: cardioprotective potential. Am Heart J. 1991;121(2 Pt 2):724-729.
- (1991) Am Heart J , vol.121 , Issue.2 PART 2 , pp. 724-729
- Frishman, W.H.¹

21
- 0022219060
- Celiprolol: Pharmacokinetics and duration of pharmacodynamic activity
- Caruso FS, Doshan HD, Hernandez PH, et al. Celiprolol: pharmacokinetics and duration of pharmacodynamic activity. Br J Clin Pract Suppl. 1985;40:12-16. (Pubitemid 16050218)
- (1985) British Journal of Clinical Practice , vol.40 , pp. 12-16
- Caruso, F.S.¹ Doshan, H.D.² Hernandez, P.H.³

22
- 0027229944
- 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and β-adrenoceptor subtype specific occupancy of celiprolol in healthy man
- DOI 10.1007/BF00316470
- de Mey C, Beithaupt K, Palm D, et al. Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man. Eur J Clin Pharmacol. 1993;44:341-348. (Pubitemid 23153451)
- (1993) European Journal of Clinical Pharmacology , vol.44 , Issue.4 , pp. 341-348
- De May, C.¹ Beithaupt, K.² Palm, D.³ Fuhr, U.⁴ Belz, G.G.⁵

23
- 0037146862
- 1 gene in rats
- DOI 10.1016/S0014-2999(02)02648-1, PII S0014299902026481
- Tsubokou Y, Kobayashi N, Mita S, et al. Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats. Eur J Pharmacol. 2002;457:85-93. (Pubitemid 35447650)
- (2002) European Journal of Pharmacology , vol.457 , Issue.2-3 , pp. 85-93
- Tsubokou, Y.¹ Kobayashi, N.² Mita, S.-I.³ Yoshida, K.⁴ Matsuoka, H.⁵

24
- 0242609837
- Celiprolol Activates eNOS through the PI3K-Akt Pathway and Inhibits VCAM-1 Via NF-κB Induced by Oxidative Stress
- DOI 10.1161/01.HYP.0000097547.35570.70
- Kobayashi N, Mita S, Yoshida K, et al. Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 Via NF-kappaB induced by oxidative stress. Hypertension. 2003;42:1004-1013. (Pubitemid 37413745)
- (2003) Hypertension , vol.42 , Issue.5 , pp. 1004-1013
- Kobayashi, N.¹ Mita, S.-I.² Yoshida, K.³ Honda, T.⁴ Kobayashi, T.⁵ Hara, K.⁶ Nakano, S.⁷ Tsubokou, Y.⁸ Matsuoka, H.⁹

25
- 83155172002
- Celiprolol increases the elasticity of the radial artery in vascular Ehlers-Danlos syndrome: A randomized controlled clinical trial
- Ong K, Collin C, Bozec E, et al. Celiprolol increases the elasticity of the radial artery in vascular Ehlers-Danlos syndrome: a randomized controlled clinical trial. Arch Cardiovasc Dis. 2009;102 (Suppl 1):S99.
- (2009) Arch Cardiovasc Dis , vol.102 , Issue.SUPPL. 1
- Ong, K.¹ Collin, C.² Bozec, E.³

26
- 0034612213
- Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment
- Boutouyrie P, Bussy C, Hayoz D, et al. Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation. 2000;101:2601-2606. (Pubitemid 30350638)
- (2000) Circulation , vol.101 , Issue.22 , pp. 2601-2606
- Boutouyrie, P.¹ Bussy, C.² Hayoz, D.³ Hengstler, J.⁴ Dartois, N.⁵ Laloux, B.⁶ Brunner, H.⁷ Laurent, S.⁸

27
- 28244441145
- Marfan's syndrome
- DOI 10.1016/S0140-6736(05)67789-6, PII S0140673605677896
- Judge DP, Dietz HC. Marfan's syndrome. Lancet. 2005;366:1965-1976. (Pubitemid 41713988)
- (2005) Lancet , vol.366 , Issue.9501 , pp. 1965-1976
- Judge, D.P.¹ Dietz, H.C.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.